TipRanks
Scancell Holdings PLC (DE:SCP)
FRANKFURT:SCP
Germany Market
SCP
Scancell Holdings
RESEARCH TOOLSreports

Scancell Holdings (SCP) Stock News & Sentiment

0 Followers
Scancell Bolsters Cancer Immunotherapy Push With Nasdaq Move and $75m Funding
Premium
Company Announcements
Scancell Bolsters Cancer Immunotherapy Push With Nasdaq Move and $75m Funding
4d ago
Scancell Sets Vote on Neuphoria Merger and 10-for-1 Share Consolidation
Premium
Company Announcements
Scancell Sets Vote on Neuphoria Merger and 10-for-1 Share Consolidation
11d ago
Scancell Secures Up to US$25m BlackRock Debt to Drive iSCIB1+ Phase 3
Premium
Company Announcements
Scancell Secures Up to US$25m BlackRock Debt to Drive iSCIB1+ Phase 3
19d ago
Scancell’s Phase 3 Melanoma Vaccine Trial Moves Toward Launch, Raising Long-Term Upside Questions
Premium
Company Announcements
Scancell’s Phase 3 Melanoma Vaccine Trial Moves Toward Launch, Raising Long-Term Upside Questions
1M ago
SCLP
Scancell to Highlight Late-Stage Cancer Immunotherapy and U.S. Deal Plans at Wainwright Conference
Premium
Company Announcements
Scancell to Highlight Late-Stage Cancer Immunotherapy and U.S. Deal Plans at Wainwright Conference
1M ago
Scancell Wins UK Green Light for Global Phase 3 Melanoma Trial of iSCIB1+
Premium
Company Announcements
Scancell Wins UK Green Light for Global Phase 3 Melanoma Trial of iSCIB1+
2M ago
Scancell Extends CSO Share Option Exercise Period
Premium
Company Announcements
Scancell Extends CSO Share Option Exercise Period
2M ago
More DE:SCP News >

SCP News on the Web

Scancell revs up for Nasdaq listing as cancer vaccine developer prepares phase III melanoma trial
Proactive Investors
Bullish
Scancell Holdings secures $25m financing as it advances melanoma trial
Proactive Investors
Bullish
Scancell Secures Up to US$25m BlackRock Debt to Drive iSCIB1+ Phase 3
TipRanks News
Neutral
Scancell secures UK clearance for late-stage melanoma trial
Proactive Investors
Bullish
Scancell sees high demand in retail share offer, seals £15.7m from UK investors
Proactive Investors
Bullish
Scancell Raises £15.7m After Oversubscribed Retail Offer and UK Placing
TipRanks News
Neutral
Scancell in advanced talks on Neuphoria reverse merger and Nasdaq listing
TipRanks News
Neutral
Scancell CFO to step down as cancer immunotherapy developer names interim replacement
Proactive Investors
Bullish

News Score - Last 7 Days

Neutral
DE:SCP
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:SCP’s Media Buzz Sentiment?
2 articles about DE:SCP were published this week. In an average week, 1 articles are published.
    What is DE:SCP’s weekly average amount of articles?
    In an average week, 1 articles about DE:SCP are published.
      What is DE:SCP’s News Sentiment?
      100% of articles about DE:SCP were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        IQVIQVIA Holdings
        GILDGilead Sciences
        ABBVAbbVie
        VRTXVertex Pharmaceuticals
        NVSNovartis
        Showing the stocks with the most bullish news sentiment over the past week